[SIST Seminar] A New Frontier of Multimodal Imaging: Combining Optics and MRI

ON2020-12-02TAG: ShanghaiTech UniversityCATEGORY: Lecture


Speaker:   Prof. Wuwei Ren

Time:       15:00-16:00, Dec. 4

Location:  SIST 1C 101

Host:       SIST



Multimodal in vivo imaging has been gaining momentum in the last decades as a new conceptual approach to enable better insights into physiological and pathological processes. Generally, the properties of existing clinical imaging modalities are appropriate for rendering diverse anatomical and functional contrast from living tissues. MRI, X-ray CT and ultrasound are commonly employed to visualize internal structures, while PET and SPECT and optical imaging techniques aim at identifying cellular and molecular pathways corresponding to early stages of disease. Multimodal imaging is then becoming the standard in clinical practice to compensate for the known deficiencies of stand-alone modalities. In this talk we will introduce the latest progress of multimodal imaging combining optics and MRI. Several multimodal systems allowing simultaneous MRI and optical readout will be covered, including MRI-Fluorescence tomography and MRI-Optoacoustic tomography. 



Dr. Wuwei Ren received his bachelor, master, and PhD degrees from Zhejiang University China (2010), KTH Sweden (2012), and ETH Zurich Switzerland (2018), respectively. Dr. Ren received his postdoctoral training at University of Zurich, Switzerland. He was also a visiting scholar at University College London, UK. Currently, Dr. Ren serves as a tenure-track assistant professor at ShanghaiTech University. His work has been published in top journals such as IEEE T-BME, Opt Express, Inverse Prob & Img, Neurophotonics, etc. His optical imaging prototype has won several European entrepreneurial awards including VentureKick award and exhibited in Swiss Innovation Pavilion, Hannover Messe (2019). Now he is leading the Molecular Imaging and Biophotonics Laboratory with the aim of pioneering the next-generation medical imaging tools for early diagnostics, drug development, and image-guided surgery.